CALC
CALC
NASDAQ · Pharmaceuticals

Calcimedica Inc

$1.36
+0.06 (+4.62%)
As of Nov 8, 11:14 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +2,599.3% upside
Low Target $29.06
Average Target $36.71
High Target $43.55
Current Price $1.36
Current
$1.36
Target
$36.71
$29.06 $36.71 avg $43.55
Scenario Analysis
Bear Case
$29.06
2,036.8%
Low target
Base Case
$36.71
+2,599.3%
Avg target
Bull Case
$43.55
+3,102.2%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$36.00
-96.2% from high
52-Week Low
$1.00
+36.0% from low
Target vs 52W High
$36.71
+2.0% vs high
Next Earnings Report
Nov 10, 2026
Today
EPS Est: $-1.30
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -5.2%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +6.5%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +7.8%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.0%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +154.9%